Janssen Pharmaceutica is a pharmaceutical company headquartered in Beerse, Belgium and owned by Johnson & Johnson. It was founded in 1953 by Paul Janssen. In 1961, Janssen Pharmaceutica was purchased by New Jersey-based American corporation Johnson & Johnson, and became part of Johnson & Johnson Pharmaceutical Research and Development (J&J PRD), now renamed to Janssen Research and Development (JRD), which conducts research and development activities related to a wide range of human medical disorders, including mental illness, neurological disorders, anaesthesia and analgesia, gastrointestinal disorders, fungal infection, HIV/AIDS, allergies and cancer. Janssen and Ortho-McNeil Pharmaceutical have been placed in the Ortho-McNeil-Janssen group within Johnson & Johnson Company.

Massachusetts General Hospital was established to provide care to Boston's sick, regardless of socioeconomic status—an innovative idea in 1811. In the words of their founder, John Warren, MD, “When in distress, every man becomes their neighbor.” They subsequently became the first teaching hospital for Harvard University’s new medical school and have been redefining excellence in healthcare ever since. They have remained at the forefront of medicine by fostering a culture of collaboration, pushing the boundaries of medical research, educating the brightest medical minds and maintaining an unwavering commitment to the diverse community they were created to serve. They believe that because of diversity they excel, through inclusion they respect their community, and with a keen focus on equity they serve, heal, educate and innovate at the highest levels. Their first priority is the well-being of their patients—near and far. As a team they are able to maintain a singular focus on providing the highest quality, most compassionate care to each and every patient.

Broad Life Sciences (Wuhan) Co., Ltd., established on 2003-08-04, Business scope includes licensed projects:pharmaceutical production;Drug Wholesale;Drug import and export;Pharmaceutical commissioned production(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)General project:Chemical product sales(No licensed chemical products);Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Medical Research and Experimental Development(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Pharnext is an advanced clinical-stage biopharmaceutical company founded in April 2007 by renowned scientists and entrepreneurs including Professor Daniel Cohen and collaborators, pioneers in modern genomics. The company develops new therapeutics for neurodegenerative diseases - orphan and common – where there are currently no cures and existing therapies available. Pharnext is the pioneer of a new paradigm for the discovery of medicinal drugs: PLEOTHERAPY™. The R&D approach protected by Pharnext systemizes new uses of approved drugs. It is based on network pharmacology utilizing complex and extensive genomic data to identify the thousands of molecules possibly involved in a disease. From this disease molecular network, Pharnext deduces synergistic combinations of drugs already approved but for unrelated indications. These novel therapeutics called PLEODRUG™ are then developed at new optimal doses and under new formulations. They offer several key advantages: efficacy, safety, and intellectual property including several composition of matter patents already granted. The proof of concept of the PLEOTHERAPY approach was obtained with PLEODRUG PXT3003 in Charcot-Marie-Tooth disease type 1A (CMT1A) through positive and consistent Phase 2 and Phase 3 results. PLEODRUG PXT864 generated encouraging Phase 2 data in Alzheimer’s disease. They also plan to develop the same agent in other orphan and common neurodegenerative diseases such as Parkinson’s disease and amyotrophic lateral sclerosis (ALS).

China State Institute of Pharmaceutical Industry is a Chinese company located in Shanghai and ultimately controlled by the Government of China. The firm regulates pharmaceutical companies.

Beijing Landan Pharmaceutical Technology Co., Ltd., established on 2013-01-23, Business scope includes technology development,technical consulting,Technical Services,technology transfer.(Market entities independently choose business projects in accordance with the law,Carry out business activities;Items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

Hainan Jizhong Boyuan Industrial Development Co., Ltd., established on 1998-07-02, Business scope includes real estate investment,Comprehensive Development of Industry and Agriculture,hotel,hotel management,Research and development of high-tech products,building materials,Decoration Materials,interior and exterior decoration,furnish,design,electronics(Car not included),metallic material,steel,Minerals(Except for franchise),Equipment,Daily necessities,textile,Office Supplies,Wujinjiaodian,household appliances,Communication equipment,Sales of handicrafts.

Sichuan Guorui Pharmaceutical Co., Ltd., established on 2005-12-07, Business scope includes manufacturing and sales:medicine,Pharmaceutical raw materials and preparations,Health food and other food;foreign trade;Drug research and development and technical consulting services.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Yulin Yushen Industrial Zone Yuhuang Bio-Pharmaceutical Co., Ltd., established on 2013-08-16, Business scope includes western medicine,Western medicine raw materials,Chinese patent medicine,biochemical agent,Research and development of health products and technology transfer(prepare to build).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Han Rui Pharmaceutical (Jingmen) Co., Ltd., established on 2019-01-03, Business scope includes licensed projects:pharmaceutical production;Pharmaceutical commissioned production(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)General project:Import and export;Technology Import and Export;Manufacturing of basic chemical raw materials(Manufacture of licensed chemicals free of hazardous chemicals);Chemical product production(No licensed chemical products);Manufacturing of Specialty Chemical Products(Free of Hazardous Chemicals);Manufacturing of daily chemical products;Chemical product sales(No licensed chemical products);Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Sales of Class I Medical Devices;Disinfectant sales(Free of Hazardous Chemicals);Sales of labor protection products;Sales of daily chemical products;Domestic trade agent;trade broker;sales agent;Specialty Chemicals Sales(Free of Hazardous Chemicals);Biochemical product technology research and development(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Jiangsu Enhua Pharmaceutical Co., Ltd. is strategically positioned in the central nervous drug market, mainly engaged in the development, production and sales of central nervous system drugs. It is a company specializing in the market segment of central nervous drugs. The main categories include anesthesia and spirit. Class and Neurology, through years of unremitting efforts in product development, production and service, the company has established a complete series of central nervous system drug products and marketing network, and strive to build an important domestic producer and sales of central nervous system drugs. Business.

Research Development Foundation is an American private company that operates as noncommercial research organizations.

Shijiazhuang No.4 Pharmaceutical Co., Ltd. is a pharmceutical company in China. It offers medicines in forms of infusions, capsules, granules, tablets & oral liquids among others. The company was founded in 1948 and is headquartered in Hebei, CN.

Randian Nanjing Biomedical Technology Co., Ltd. is a company headquartered in China that provides drug research and development & technical services.

Annovation BioPharma, Inc. develops pharmaceutical products in the field of anesthesia, sedation and sleep. It is developing a rapid-acting anesthesia called Rapidate. The firm's novel agents are designed to allow more precise control of anesthesia and enable safer treatment of patients undergoing surgical procedures. The company was founded in 2009 by Nicholas Barker and is headquartered in Parsippany, NJ.

Sichuan Baili Pharmaceutical Co., Ltd., established on 1996-08-23, Business scope includes licensed projects:pharmaceutical production;Health food production(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)General project:Import and export;Medical Research and Experimental Development;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Cosmetics Wholesale;Healthy food(prepackaged)Sales(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).

CyDex Pharmaceuticals, Inc., a pharmaceutical company, engages in the development and commercialization of drugs specifically designed to address limitations of current therapies. It develops a portfolio of product candidates utilizing its drug formulation technology using Captisol, a group of cyclodextrins. The company's products include Geodon IM and Abilify Injection IM for bipolar disorder/schizophrenia; Vfend IV for antifungal; and Cerenia for canine motion sickness. It also develops Fosphenytoin IV and IM for status epilepticus; Melphalan IV for multiple myeloma; Topiramate IV for epilepsy; Amiodarone IV for arrhythmia; Budesonide Solution Inhalation for asthma; Clopidogrel IV for atherothrombosis; and Budesonide/Azelastine Nasal Spray for allergic rhinitis. In addition, the company out license its technology to third parties for use in the development of their products. CyDex Pharmaceuticals, Inc. was formerly known as CyDex, Inc. and it changed its name in November 2007. The company was founded in 1993 and is based in Lenexa, Kansas.

Cisen Pharmaceutical Ltd. engages in the manufacturing of comprehensive chemical and pharmaceutical products. It sells liver, antitumor & auxiliary, nutrition, cardiovascular, antibiotics, sedation anesthesia snooze, digestive system, cough & asthma class, immunomodulator, basic infusion, therapeutic infusion, polypropylene ampoules disease drugs. The company key products include Dirithromycin Enteric-coated Capsules, Voglibose Capsules, Cycloclenbuterol Hydrochloride Tablets, Pantoprazole Sodium Enteric-Coated Tablets, Dexmedetomidine Hydrochloride, Sodium Chloride, Iohexol, Oxaliplatin & Mannitol Injection, Adefovir Dipivoxil Tablets, Glycerol Fructose & Sodium Chloride Injection and other related drugs. Cisen Pharmaceutical was founded on November 6, 1998 and is headquartered in Jining, China.

Xuzhou Yihua Pharmaceutical Technology Co., Ltd., established on 2000-06-05, Business scope includes;none.;Research and development of medicine,Health Supplies,Relevant chemicals provide technology transfer,consultation service(Except for special regulations of the state).

Jiangsu Enhua Luokang Drug Research and Development Co., Ltd., established on 2014-08-29, Business scope includes pharmaceutical product research and development and technology transfer,Pharmaceutical Intermediates,medicine,Chemical and biological engineering technology development,technology transfer,Technical Advisory Services,Pharmaceutical R&D Outsourcing Services,Self-operated and agent import and export business of various commodities and technologies(Except for commodities and technologies that are restricted or prohibited from import and export by the state).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)